Results · Apr-Jun 2026
Pharmaids Pharmaceuticals Q1 FY27 results
Sales fell 38% to ₹4.1 crore from ₹6.7 crore in Apr-Jun 2025.
Operating profit was −₹0.74 crore, an operating margin of −18.1% (up 63.1 points from a year ago).
Net profit turned positive: ₹1.9 crore against a loss of ₹5.3 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −43%, net profit turns positive.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 4.1 | 6.7 | −38% |
| Operating profit (EBITDA) | -0.7 | -5.4 | n/m |
| Operating margin | −18.1% | −81.2% | +63.1 pts |
| Net profit | 1.9 | -5.3 | turns positive |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.